James M. Daly sold Acadia Pharmaceuticals Inc. ($ACAD) shares once on the open market in the last year, totaling $671,000, with the most recent sale on November 10, 2025. This places him 5,842nd out of 11,678 insiders by sales value, below the average of $8.6 million across 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | CYTOKINETICS INC | $CYTK | Daly James M | Director | A | Common Stock | 197 | $63.44 | 197.0000 | 122,264,929 | 9999.99% | 0.00% |
| Nov. 10, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | S | Common Stock | 30000 | $22.37 | 4,041.0000 | 170,650,000 | 88.13% | 0.02% |
| Aug. 19, 2025 | CYTOKINETICS INC | $CYTK | Daly James M | Director | A | Non-Qualified Stock Option (Right to Buy) | 27450 | $0.00 | 27,450.0000 | 118,410,689 | 9999.99% | 0.02% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | A | Stock Option (Right to Buy) | 1290 | $0.00 | 1,290.0000 | 22,080,246 | 9999.99% | 0.01% |
| June 20, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | A | Common Stock | 715 | $0.00 | 2,627.0000 | 22,080,246 | 37.40% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | M | Common Stock | 9387 | $0.00 | 34,041.0000 | 166,362,000 | 38.07% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | A | Restricted Stock Units | 8107 | $0.00 | 8,107.0000 | 166,362,000 | 9999.99% | 0.00% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | A | Director Stock Options (Right to Buy) | 13793 | $0.00 | 13,793.0000 | 166,362,000 | 9999.99% | 0.01% |
| May 29, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | M | Restricted Stock Units | 9387 | $0.00 | 0.0000 | 166,362,000 | 100.00% | 0.01% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Stock Option (Right to Buy) | 6000 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.03% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 770 | $348.94 | 1,912.0000 | 22,080,246 | 28.71% | 0.00% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Stock Option (Right to Buy) | 9470 | $0.00 | 0.0000 | 22,080,246 | 100.00% | 0.04% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 14302 | $347.39 | 2,682.0000 | 22,080,246 | 84.21% | 0.06% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 398 | $346.90 | 16,984.0000 | 22,080,246 | 2.29% | 0.00% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Common Stock | 6000 | $111.06 | 17,382.0000 | 22,080,246 | 52.71% | 0.03% |
| Feb. 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Common Stock | 9470 | $65.06 | 11,382.0000 | 22,080,246 | 495.29% | 0.04% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Not found | A | Stock Option (Right to Buy) | 1105 | $0.00 | 1,105.0000 | 0 | 9999.99% | 0.00% |
| June 25, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Not found | A | Common Stock | 714 | $0.00 | 1,912.0000 | 0 | 59.60% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | M | Restricted Stock Units | 6652 | $0.00 | 0.0000 | 163,819,000 | 100.00% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | M | Common Stock | 6652 | $0.00 | 24,654.0000 | 163,819,000 | 36.95% | 0.00% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | A | Director Stock Options (Right to Buy) | 15959 | $0.00 | 15,959.0000 | 163,819,000 | 9999.99% | 0.01% |
| May 29, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Not found | A | Restricted Stock Units | 9387 | $0.00 | 9,387.0000 | 163,819,000 | 9999.99% | 0.01% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 500 | $265.49 | 1,472.0000 | 0 | 25.35% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Common Stock | 10912 | $105.08 | 12,110.0000 | 0 | 910.85% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 842 | $243.26 | 11,268.0000 | 0 | 6.95% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 6279 | $244.19 | 4,989.0000 | 0 | 55.72% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 2991 | $244.89 | 1,998.0000 | 0 | 59.95% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 557 | $246.30 | 1,441.0000 | 0 | 27.88% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 43 | $247.03 | 1,398.0000 | 0 | 2.98% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 200 | $248.45 | 1,198.0000 | 0 | 14.31% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Stock Option (Right to Buy) | 1577 | $0.00 | 10,912.0000 | 0 | 12.63% | 0.00% |
| April 2, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Stock Option (Right to Buy) | 10912 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 800 | $262.01 | 2,501.0000 | 0 | 24.24% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 200 | $259.11 | 3,301.0000 | 0 | 5.71% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 1460 | $258.28 | 3,501.0000 | 0 | 29.43% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 3604 | $257.30 | 4,961.0000 | 0 | 42.08% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 7401 | $256.50 | 8,565.0000 | 0 | 46.35% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 6809 | $255.64 | 15,966.0000 | 0 | 29.90% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Common Stock | 20000 | $100.45 | 21,198.0000 | 0 | 1669.45% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | M | Common Stock | 1577 | $105.08 | 22,775.0000 | 0 | 7.44% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 178 | $263.31 | 2,323.0000 | 0 | 7.12% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 351 | $264.89 | 1,972.0000 | 0 | 15.11% | 0.00% |
| April 1, 2024 | MADRIGAL PHARMACEUTICALS, INC. | $MDGL | Daly James M | Director | S | Common Stock | 274 | $266.91 | 1,198.0000 | 0 | 18.61% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Common Stock | 6391 | $0.00 | 9,450.0000 | 0 | 208.92% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Common Stock | 8552 | $0.00 | 18,002.0000 | 161,683,000 | 90.50% | 0.01% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | A | Director Stock Options (Right to Buy) | 11045 | $0.00 | 11,045.0000 | 161,683,000 | 9999.99% | 0.01% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Restricted Stock Units | 3059 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | A | Restricted Stock Units | 6652 | $0.00 | 6,652.0000 | 161,683,000 | 9999.99% | 0.00% |
| June 7, 2022 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Restricted Stock Units | 6391 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 1, 2023 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Restricted Stock Units | 8552 | $0.00 | 0.0000 | 161,683,000 | 100.00% | 0.01% |
| June 22, 2021 | ACADIA PHARMACEUTICALS INC | $ACAD | Daly James M | Director | M | Common Stock | 3059 | $0.00 | 3,059.0000 | 0 | 9999.99% | 0.00% |